Joseph Lambing
2015
In 2015, Joseph Lambing earned a total compensation of $524.5K as Senior Vice President, Nonclinical and Pharmaceutical Development at MyoKardia.
Compensation breakdown
| Non-Equity Incentive Plan | $103,518 |
|---|---|
| Option Awards | $113,678 |
| Salary | $307,290 |
| Other | $500 |
| Total | $524,486 |
Lambing received $307.3K in salary, accounting for 59% of the total pay in 2015.
Lambing also received $103.5K in non-equity incentive plan, $113.7K in option awards and $500 in other compensation.
Rankings
In 2015, Joseph Lambing's compensation ranked 10,641st out of 13,638 executives tracked by ExecPay. In other words, Lambing earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,641 out of 13,638 | 22nd |
Division Manufacturing | 4,056 out of 5,190 | 22nd |
Major group Chemicals And Allied Products | 1,491 out of 1,854 | 20th |
Industry group Drugs | 1,229 out of 1,528 | 20th |
Industry Pharmaceutical Preparations | 963 out of 1,182 | 19th |
Source: SEC filing on April 28, 2016.
Lambing's colleagues
We found two more compensation records of executives who worked with Joseph Lambing at MyoKardia in 2015.